Cargando…

(11R,13R)-13-(Tetra­lin-1-ylamino)-4,5-ep­oxy-11,13-dihydro­costunolide

The title compound [systematic name: (12R)-4,8-dimethyl-12-[(1′R)-1′,2′,3′,4′-tetrahydro-1′-naphthyl)aminomethyl]-3,14-dioxatricyclo[9.3.0.0(2,4)]tetradec-7-en-13-one}, C(25)H(33)NO(3), was formed from the reaction of (1R)-1-amino­tetra­lin with parthenolide in methano­lic solution. X-ray crystal st...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasim, Shama, Parkin, Sean, Crooks, Peter A.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2960798/
https://www.ncbi.nlm.nih.gov/pubmed/21201970
http://dx.doi.org/10.1107/S1600536808003322
Descripción
Sumario:The title compound [systematic name: (12R)-4,8-dimethyl-12-[(1′R)-1′,2′,3′,4′-tetrahydro-1′-naphthyl)aminomethyl]-3,14-dioxatricyclo[9.3.0.0(2,4)]tetradec-7-en-13-one}, C(25)H(33)NO(3), was formed from the reaction of (1R)-1-amino­tetra­lin with parthenolide in methano­lic solution. X-ray crystal structure analysis determined that the configuration of the new chiral center in the title compound was R.